Chronic Urticaria
Showing 26 - 50 of >10,000
Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)
Recruiting
- Chronic Inducible Urticaria
- Oral EP262
-
Tampa, Florida
- +5 more
Sep 18, 2023
Chronic Spontaneous Urticaria Trial in Germany, United States (CDX-0159, Normal Saline)
Completed
- Chronic Spontaneous Urticaria
- CDX-0159
- Normal Saline
-
Birmingham, Alabama
- +13 more
Jan 24, 2023
Chronic Idiopathic Urticaria Trial (5-mg Desloratadine, 10-mg Desloratadine, 20-mg Desloratadine)
Completed
- Chronic Idiopathic Urticaria
- 5-mg Desloratadine
- +2 more
- (no location specified)
Feb 7, 2022
STOP CSUA: phySical acTivity, mOod and sleeP in Chronic
Not yet recruiting
- Chronic Spontaneous Urticaria
- Physical activity monitoring - Symptom monitoring
-
Dublin, IrelandSt. James's Hospital
Dec 13, 2021
URTICARIA Trial in Paris Cedex 10 (Rupatadine Fumarate)
Terminated
- URTICARIA
- Rupatadine Fumarate
-
Paris Cedex 10, FranceHospital Saint Louis
Feb 2, 2022
Chronic Urticaria Trial in United States (TEV-45779, XOLAIR® Injection)
Recruiting
- Chronic Urticaria
- TEV-45779
- XOLAIR® Injection
-
Bakersfield, California
- +8 more
Dec 16, 2021
Chronic Cold Urticaria Trial in Leiden (THB001)
Recruiting
- Chronic Cold Urticaria
-
Leiden, NetherlandsCentre for Human Drug Research
Aug 19, 2022
Chronic Idiopathic Urticaria, Atopy Trial (desloratadine, Placebo)
Completed
- Chronic Idiopathic Urticaria
- Atopy
- desloratadine
- Placebo
- (no location specified)
Feb 7, 2022
Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Rash Trial in Dhaka (Fexofenadine Hydrochloride Topical Lotion 1% (OP2101))
Recruiting
- Atopic Dermatitis
- +11 more
- Fexofenadine Hydrochloride Topical Lotion 1% (OP2101)
-
Dhaka, Ramna, BangladeshBCT Ltd.
Jul 13, 2022
Chronic Inducible Urticaria Trial (Remibrutinib, Placebo)
Not yet recruiting
- Chronic Inducible Urticaria
- Remibrutinib
- Placebo
- (no location specified)
Jul 28, 2023
Chronic Spontaneous Urticaria Trial in Worldwide (Benralizumab, Placebo and Benralizumab)
Active, not recruiting
- Chronic Spontaneous Urticaria
- Benralizumab
- Placebo and Benralizumab
-
Scottsdale, Arizona
- +39 more
Jan 16, 2023
Chronic Spontaneous Urticaria, Recurrent Angioedema Trial in Germany (Dupilumab, Placebo)
Completed
- Chronic Spontaneous Urticaria
- Recurrent Angioedema
- Dupilumab
- Placebo
-
Marburg, Hessen, Germany
- +5 more
Feb 1, 2022
Chronic Inducible Urticaria Trial in United States (barzolvolimab, Matching Placebo)
Recruiting
- Chronic Inducible Urticaria
- barzolvolimab
- Matching Placebo
-
Birmingham, Alabama
- +31 more
Jan 20, 2023
Chronic Spontaneous Urticaria Trial in Warszawa (CT-P39, EU-approved Xolair)
Recruiting
- Chronic Spontaneous Urticaria
- CT-P39
- EU-approved Xolair
-
Warszawa, PolandKlinika Ambroziak ESTEDERM
Aug 25, 2021
Chronic Spontaneous Urticaria Trial in Grenoble (association of levocetirizine and tranexamic acid, Levocetirizine only)
Recruiting
- Chronic Spontaneous Urticaria
- association of levocetirizine and tranexamic acid
- Levocetirizine only
-
Grenoble, FranceCHU Grenoble-Alpes
Apr 27, 2021
Urticaria Chronic Trial in Baltimore (Omalizumab)
Completed
- Urticaria Chronic
-
Baltimore, MarylandJohns Hopkins Asthma and Allergy Center
May 20, 2021